Infacol

Simeticone, the active ingredient in Infacol, is an antiflatulent presented as an oral liquid for oral use. It reduces gas bubbles in the gastrointestinal tract, providing relief from colic and flatulence in infants and other patients experiencing excessive gas. The medication is available over‑the‑counter in the European market and is intended for short‑term relief of gas‑related discomfort.

GNH USA supplies Infacol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infacol, a simeticone‑based antiflatulent, acts on gastrointestinal gas accumulation.

Infant colic: reduces discomfort caused by trapped gas in infants, helping to soothe prolonged crying episodes. Infant gas: alleviates excessive intestinal gas and associated irritability in newborns and young babies. Adult flatulence: provides rapid relief from bloating, pressure and gas‑related discomfort in adults.

Simeticone is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Mild nausea or stomach upset - Transient vomiting - Diarrhoea or loose stools - Unpleasant taste in the mouth - Mild oral irritation - Increased flatulence after initial dose

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling) - Anaphylaxis (difficulty breathing, throat swelling) - Severe skin reactions such as Stevens‑Johnson syndrome - Persistent vomiting or severe abdominal pain - Hypersensitivity leading to angio‑edema

When using Infacol, consider the following precautions. - Age limitation: Use in infants only under medical guidance and not in newborns younger than two weeks unless advised. - Dosage adherence: Do not exceed the recommended amount indicated by a healthcare professional. - Underlying conditions: Seek medical advice if symptoms persist beyond a few days or worsen. - Hypersensitivity: Discontinue use and consult a clinician if any signs of allergic reaction appear. - Drug interactions: Inform the prescriber of all concurrent medications, especially those requiring gastric absorption. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Simeticone has low systemic absorption, yet certain co‑administered drugs may be affected.

Major Interactions (Avoid): - None identified: Simeticone does not exhibit clinically significant major drug interactions. - Concurrent use with other antiflatulents: may increase gastrointestinal side effects.

Moderate Interactions (Monitor Closely): - Tetracycline antibiotics: Simeticone may reduce absorption if taken simultaneously; separate dosing by at least 2 hours. - Iron or calcium supplements: possible decreased mineral absorption; stagger administration. - Levothyroxine: potential reduction in thyroid hormone absorption; advise spacing doses. - Antifungal agents (e.g., ketoconazole): may experience reduced bioavailability when co‑administered.